Shandong Buchang Pharmaceuticals Co Ltd (603858) — Net Asset Quality Index
Shandong Buchang Pharmaceuticals Co Ltd (603858) has a Net Asset Quality Index of 51.5% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥19.57 Billion minus total liabilities of CN¥9.50 Billion yields net assets of CN¥10.07 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check Shandong Buchang Pharmaceuticals Co Ltd (603858) asset resilience to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Shandong Buchang Pharmaceuticals Co Ltd Net Asset Quality Index Over Time (2011–2024)
This chart shows how Shandong Buchang Pharmaceuticals Co Ltd's Net Asset Quality Index has evolved across 14 annual periods from 2011 to 2024. As of September 2025, the index stands at 51.5%, representing net assets of CN¥10.07 Billion against total assets of CN¥19.57 Billion CNY. See Shandong Buchang Pharmaceuticals Co Ltd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Shandong Buchang Pharmaceuticals Co Ltd (2011–2024)
The table below presents the year-by-year Net Asset Quality Index for Shandong Buchang Pharmaceuticals Co Ltd from 2011 to 2024, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see market cap of Shandong Buchang Pharmaceuticals Co Ltd.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 50.7% | CN¥9.81 Billion | CN¥19.33 Billion | CN¥9.52 Billion | ▼ -3.7 pp |
| 2023 | 54.5% | CN¥11.38 Billion | CN¥20.89 Billion | CN¥9.52 Billion | ▼ -1.5 pp |
| 2022 | 55.9% | CN¥12.28 Billion | CN¥21.95 Billion | CN¥9.68 Billion | ▼ -4.3 pp |
| 2021 | 60.2% | CN¥14.45 Billion | CN¥23.99 Billion | CN¥9.54 Billion | ▼ -0.1 pp |
| 2020 | 60.3% | CN¥13.81 Billion | CN¥22.89 Billion | CN¥9.08 Billion | ▼ -4.7 pp |
| 2019 | 65.1% | CN¥13.79 Billion | CN¥21.19 Billion | CN¥7.40 Billion | ▼ -4.1 pp |
| 2018 | 69.2% | CN¥13.86 Billion | CN¥20.03 Billion | CN¥6.17 Billion | ▲ +0.3 pp |
| 2017 | 68.9% | CN¥13.22 Billion | CN¥19.20 Billion | CN¥5.98 Billion | ▲ +0.8 pp |
| 2016 | 68.1% | CN¥12.71 Billion | CN¥18.67 Billion | CN¥5.96 Billion | ▲ +22.0 pp |
| 2015 | 46.1% | CN¥7.26 Billion | CN¥15.76 Billion | CN¥8.50 Billion | ▼ -2.8 pp |
| 2014 | 48.9% | CN¥4.45 Billion | CN¥9.10 Billion | CN¥4.65 Billion | ▼ -12.9 pp |
| 2013 | 61.7% | CN¥4.28 Billion | CN¥6.94 Billion | CN¥2.66 Billion | ▼ -9.2 pp |
| 2012 | 71.0% | CN¥4.02 Billion | CN¥5.67 Billion | CN¥1.65 Billion | ▲ +7.9 pp |
| 2011 | 63.1% | CN¥2.80 Billion | CN¥4.44 Billion | CN¥1.64 Billion | — |